SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations (India) informs about receipt of award

21 Apr 2022 Evaluate

Syncom Formulations (India) has informed that the Company has been awarded by INDIA 100 SME AWARDS organized by India' SME Forum in overall evaluation of Financial & Non-Financial Parameters amongst 37134 Nominations organized on 13th April, 2022 at Taj Palace, New Delhi. The copy of recognition certificate is here attached.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

13.99 -0.22 (-1.55%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: